These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21728760)

  • 21. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.
    Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V
    J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.
    Kumar S; Randhawa JK
    Colloids Surf B Biointerfaces; 2013 Feb; 102():562-8. PubMed ID: 23104026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
    Kuo YC; Ko HF
    Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and performance evaluation of saquinavir laden cationic submicron emulsions.
    Jain V; Prasad V; Jadhav P; Mishra PR
    Drug Deliv; 2009 Jan; 16(1):37-44. PubMed ID: 19555307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia.
    Kuo YC; Wang CC
    Colloids Surf B Biointerfaces; 2013 Jan; 101():101-5. PubMed ID: 22796778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies.
    Shah M; Chuttani K; Mishra AK; Pathak K
    Drug Dev Ind Pharm; 2011 May; 37(5):526-37. PubMed ID: 21128704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced systemic exposure of saquinavir via the concomitant use of curcumin-loaded solid dispersion in rats.
    Kim SA; Kim SW; Choi HK; Han HK
    Eur J Pharm Sci; 2013 Aug; 49(5):800-4. PubMed ID: 23748001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
    Kuo YC; Su FL
    Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
    Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK; Lim SJ; Kim CK
    Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
    Branham ML; Moyo T; Govender T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A; Al-Kassas R
    Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.
    B A; D N; Veerabrahma K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
    Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
    Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.